Merck & Co »

Entrada Therapeutics shares owned by Merck & Co

Quarter-by-quarter ownership of Entrada Therapeutics shares owned by Merck & Co from 13F filings

Historical chart of Merck & Co investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Merck & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Merck & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 1.7M 5.80
2025-06-30 $12M 1.7M 6.72

Top funds holding Entrada Therapeutics